Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11 (Search time: 0.007 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
1999The Batten disease gene product (CLN3p) is a Golgi integral membrane proteinKremmidiotis, G.; Lensink, I.; Bilton, R.; Woollatt, E.; Chataway, T.; Sutherland, G.; Callen, D.
1995Integration of transcript and genetic maps of chromosome 16 at near-1-Mb resolution: demonstration of a 'hot-spot' for recombination at 16p12Callen, D.; Lane, S.; Kozman, H.; Kremmidiotis, G.; Whitmore, S.; Lowenstein, M.; Doggett, N.; Kenmochi, N.; Page, D.; Maglott, D.; Nierman, W.; Murakawa, K.; Sikela, J.; Houlgatte, R.; Auffray, C.; Sutherland, G.
1995Paracentric inversions do not normally generate monocentric recombinant chromosomesSutherland, G.; Callen, D.; McKinlay Gardner, R.
2002Study of 250 children with idiopathic mental retardation reveals nine cryptic and diverse subtelomeric chromosome anomaliesBaker, E.; Hinton, L.; Callen, D.; Altree, M.; Dobbie, A.; Eyre, H.; Sutherland, G.; Thompson, E.; Thompson, P.; Woollatt, E.; Haan, E.
2002Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genesPowell, J.; Gardner, A.; Bais, A.; Hinze, S.; Baker, E.; Whitmore, S.; Crawford, J.; Kochetkova, M.; Spendlove, H.; Doggett, N.; Sutherland, G.; Callen, D.; Kremmidiotis, G.
2004Aberrant CBFA2T3B gene promoter methylation in breast tumorsBais, A.; Gardner, A.; McKenzie, O.; Callen, D.; Sutherland, G.; Kremmidiotis, G.
1997High resolution characterisation of an interstitial deletion of less than 1.9Mb at 4p16.3 associated with Wolf-Hirschhorn SyndromeFang, Y.; Bain, S.; Haan, E.; Eyre, H.; MacDonald, M.; Wright, T.; Altherr, M.; Riess, O.; Sutherland, G.; Callen, D.
1999C160rf5, a novel proline-rich gene at 16p13.3, is highly expressed in the brainBhalla, K.; Eyre, H.; Whitmore, S.; Sutherland, G.; Callen, D.
2002CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3Kochetkova, M.; McKenzie, O.; Bais, A.; Martin, J.; Secker, G.; Seshadri, R.; Powell, J.; Hinze, S.; Gardner, A.; Spendlove, H.; O'Callaghan, N.; Cleton-Jansen, A.; Cornelisse, C.; Whitmore, S.; Crawford, J.; Kremmidiotis, G.; Sutherland, G.; Callen, D.
1996Positional cloning of the Fanconi anaemia group A geneApostolou, S.; Whitmore, S.; Crawford, J.; Lennon, G.; Sutherland, G.; Callen, D.; Ianzano, L.; Savino, M.; d'Apolito, M.; Notarangelo, A.; Memeo, E.; Piemontese, M.; Zelante, L.; Savoia, A.; Gibson, R.; Tipping, A.; Morgan, N.; Hassock, S.; Jansen, S.; de Ravel, T.; et al.